Table 1 Sociodemographic characteristics of the sample
Patients with Schizophrenia (N = 120) | Healthy controls (N = 60) | p-value | |
|---|---|---|---|
Frequency (%) | Frequency (%) | ||
Sex | |||
Male | 71 (59.2%) | 36 (60.0%) | 0.91 |
Female | 49 (40.8%) | 24 (40.0%) | |
Education level | |||
Complementary | 41 (34.2%) | 21 (35.0%) | 0.73 |
Secondary | 60 (50.0%) | 27 (45.0%) | |
University | 19 (15.8%) | 12 (20.0%) | |
Marital Status | |||
Single | 95 (81.9%) | 6 (10.0%) | < 0.001 |
Married | 9 (7.8%) | 52 (86.7%) | |
Widowed | 2 (1.7%) | 0 (0.0%) | |
Divorced | 10 (8.6%) | 2 (3.3%) | |
Monthly income | |||
No income | 27 (23.3%) | 0 (0.0%) | < 0.001 |
< 1000 $ | 61 (52.6%) | 39 (67.2%) | |
1000–2000 $ | 26 (22.4%) | 12 (20.7%) | |
> 2000 $ | 2 (1.7%) | 7 (12.1%) | |
Family history of psychiatric illness | |||
Yes | 42 (36.5%) | 5 (8.5%) | < 0.001 |
No | 73 (63.5%) | 54 (91.5%) | |
Mean ± SD | Mean ± SD | ||
Age | 48.4 ± 7.6 | 47.9 ± 7.4 | 0.67 |
Duration of illness (years) | 20.6 ± 12.4 | – | |
Duration of hospitalization (years) | 12.4 ± 8.5 | – | |
Number of hospitalizations | 6.3 ± 5.6 | – | |
Chlorpromazine equivalent dose (mg) | 1041.6 [Min: 0.5 – Max: 4502.0] | ||